Dean Y. Li - 01 Jul 2025 Form 4 Insider Report for RECURSION PHARMACEUTICALS, INC. (RXRX)

Role
Director
Signature
/s/ Jonathan Golightly, attorney-in-fact
Issuer symbol
RXRX
Transactions as of
01 Jul 2025
Transactions value $
$0
Form type
4
Filing time
03 Jul 2025, 15:30:26 UTC
Previous filing
23 Jun 2025
Next filing
03 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Li Dean Y Director C/O RECURSION PHARMACEUTICALS, 41 S. RIO GRANDE STREET, SALT LAKE CITY /s/ Jonathan Golightly, attorney-in-fact 03 Jul 2025 0001837016

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXRX Class A Common Stock Award $0 +1,949 +0.16% $0 1,236,567 01 Jul 2025 Direct F1
holding RXRX Class A Common Stock 1,422,048 01 Jul 2025 By Dean Y. Li Revocable Trust
holding RXRX Class A Common Stock 136,981 01 Jul 2025 By Dean Y. Li GRAT
holding RXRX Class A Common Stock 421,000 01 Jul 2025 By Dean Y. Li 2021 Family Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.